Part-Time
Physician – Virtual Health Assessment
Oscar Health
1,001-5,000 employees
Tech-driven health insurance with virtual care
No salary listed
New York, NY, USA
Remote
Remote in New York with occasional travel for team meetings.
MD
 Medical, Clinical & Veterinary |
|---|
Get referred to Oscar Health
See people who can refer or advise you
- Board-certification in Internal Medicine or Family Medicine
- MD or DO from an accredited medical school
- Must be licensed in TN and FL or Texas (full license, not telehealth)
- Active IMLCC or eligible to apply
- Willingness to be licensed in additional states with our licensing vendor assistance
- 3+ years experience in an outpatient family or internal medicine practice
- Experience with value based care documentation standards
- Provide direct oversight and supervision of nurse practitioners and physician assistants within state by state regulations
- Provide medical care virtually (by phone, video, & message) in alignment with Oscar Medical Group guidelines, practices and policies
- Collaborate with medical assistants, registered nurses, and other providers across service lines
- Compliance with all applicable laws and regulations
- Other duties as assigned
- 2+ years of Telemedicine experience
- Spanish fluency
- Regulatory supervision experience of Nurse Practitioners and Physician Assistants
Oscar Health is a U.S. health insurer that uses technology to simplify health care for individuals, families, and small businesses, offering ACA-compliant and other plans. Its products run on a digital platform with 24/7 virtual care and tools to find in-network doctors, hospitals, and pharmacies, plus cost-management features. It differentiates itself with a tech-driven member experience, high accessibility, round-the-clock telemedicine, and clear access to in-network providers. The goal is to make healthcare simple, accessible, and affordable in the United States by streamlining enrollment, care access, and costs.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
New York City, New York
Founded
2012
Get referred to Oscar Health
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q2 2026 revenue hit $4.88 billion and operating income reached $388.6 million.
- Oscar raised 2026 operating guidance to $500 million-$700 million after strong first-half results.
- ICHRAx expands employer distribution, targeting gig and small-business coverage demand into 2027.
What critics are saying
- 93% of 2025 premiums came from CMS subsidies, exposing Oscar to policy shocks.
- House Judiciary subpoenaed Oscar in February 2026 over Obamacare subsidy fraud and compliance.
- CMS eligibility reviews and RADV audits threaten 2026 membership, revenue, and capital.
What makes Oscar Health unique
- Oscar's 20-state ACA footprint and 3.4 million members create national scale.
- Lucie, ICHRAx, and Healthinsurance.org build a vertically integrated enrollment and distribution stack.
- Oswell AI routes one in four members to cheaper care sites.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health insurance - That’s a given. Employees and their families receive incredible health insurance.
Financial benefits - A penny saved....we’re talking about a 401K plan, health savings accounts, and more.
Well @ Oscar - We care about your wellness with fitness classes and access to mental health support.
Work-Life Balance - We offer multiple time-off options, wellness days, and 10+ weeks of parental leave.
Learning & Development - We offer everything from mentorship to management training.
Growth & Insights and Company News
6 month growth
↓ -1%1 year growth
↓ -1%2 year growth
↓ -1%Oscar Health reported record first-half profitability of $1 billion in net income for the first half of 2026, driven by disciplined pricing and a scalable technology platform. The company raised its full-year earnings from operations guidance to $500 million–$700 million. The insurer leveraged its proprietary AI agent "Oswell" to guide one in four members to high-value care sites, saving an average of $75 per appointment. AI-powered medical economics models are expected to generate tens of millions in annual savings by identifying pharmacy cost outliers early. Oscar recognised a $160 million favourable risk adjustment for 2025 in the second quarter. The company projects a full-year MLR between 81.5% and 82.5%, anticipating seasonal utilisation increases as members meet deductibles. The firm launched ICHRAx, an electronic data exchange platform designed to facilitate employer transitions from defined benefit to defined contribution plans.
Oscar Health beat Wall Street's revenue expectations in Q2 CY2026, reporting sales of $4.88 billion, up 70.4% year on year and 2.9% above analyst estimates of $4.74 billion. The health insurance company's GAAP profit of $1.10 per share significantly exceeded consensus estimates of $0.41. The company also reported adjusted EBITDA of $415.3 million, well above the $170.9 million analysts expected. Operating margin improved to 8%, compared with negative 8% in the same quarter last year. Free cash flow margin rose to 42.6% from 17.5% year on year. Following the results, Oscar Health's stock jumped 11.8%. Analysts expect revenue to grow 25.5% over the next 12 months.
This article examines three companies based on their cash-generating capabilities and investment potential. Starbucks, with a 9.5% trailing 12-month free cash flow margin, faces challenges including declining same-store sales and a projected 1.6% sales decline. Operating margins fell by 3 percentage points as expenses increased relative to revenue. The stock trades at 35.5x forward P/E. Inter Parfums, which manufactures fragrances for brands like Kate Spade and Van Cleef & Arpels, shows stronger fundamentals with a 14.4% free cash flow margin and 59.7% gross margin. The company trades at 24.8x forward P/E. Oscar Health, a technology-focused health insurer, demonstrates the strongest performance with 21% free cash flow margin. The company achieved 42.6% annual revenue growth over two years and 31.5% annual earnings per share growth over four years. Its free cash flow margin expanded by 19.9 percentage points over five years.
Oscar Health has attracted attention following strong revenue growth and increased exposure to the Affordable Care Act market, alongside mixed analyst views on valuation. The company reported 52.6% revenue growth and solid free cash flow, supporting its tech-focused ACA platform strategy. A family trust linked to director Mario Schlosser recently sold and converted Class A and Class B shares under a pre-arranged trading plan, representing portfolio diversification rather than a shift in ownership. The investment case centres on whether Oscar can convert revenue and membership growth into sustainable profitability whilst managing medical costs and regulation. Analysts project widely varying outcomes, with optimistic forecasts reaching $25.5 billion revenue and $1.1 billion earnings by 2029. Key risks include persistent medical cost volatility and margin sensitivity to regulatory decisions.
Oscar Health reported revenues of $4.65 billion in Q1, up 52.6% year on year, but the figure missed analysts' expectations by 5.7%. The technology-focused health insurance company, founded in 2012, delivered the weakest performance against analyst estimates amongst 12 tracked health insurance providers. Despite the underwhelming results, Oscar Health's stock has surged 67.8% since the earnings report and currently trades at $30.10. The health insurance sector overall posted strong Q1 results, with the group's revenues beating consensus estimates by 1.4%. Share prices across health insurance providers have risen 38.3% on average since the latest earnings. The sector faces ongoing challenges from regulatory scrutiny, potential government healthcare reforms and rising medical costs, though an ageing population and advances in data analytics provide tailwinds.